Health Insurance MarketplaceSM, 14855 [2016-06206]
Download as PDF
Federal Register / Vol. 81, No. 53 / Friday, March 18, 2016 / Notices
outcomes, effectiveness, and
appropriateness of health care services
and procedures to identify the manner
in which disease, disorders, and other
health conditions can be prevented,
diagnosed, treated, and managed
clinically. Section 1862(a)(1)(E) of the
Act allows Medicare to cover under
coverage with evidence development
(CED) certain items or services for
which the evidence is not adequate to
support coverage under section
1862(a)(1)(A) and where additional data
gathered in the context of a clinical
setting would further clarify the impact
of these items and services on the health
of beneficiaries.
The data collected and analyzed in
the TVT Registry will be used by CMS
to determine if the TAVR is reasonable
and necessary (e.g., improves health
outcomes) for Medicare beneficiaries
under Section 1862(a)(1)(A) of the Act.
Furthermore, data from the Registry will
assist the medical device industry and
the Food and Drug Administration
(FDA) in surveillance of the quality,
safety and efficacy of new medical
devices to treat aortic stenosis. For
purposes of the TAVR NCD, the TVT
Registry has contracted with the Data
Analytic Centers to conduct the
analyses. In addition, data will be made
available for research purposes under
the terms of a data use agreement that
only provides de-identified datasets.
Form Number: CMS–10443 (OMB
control number: 0938–1202); Frequency:
Annual; Affected Public: Individuals,
Households and Private Sector; Number
of Respondents: 14,871; Total Annual
Responses: 59,484; Total Annual Hours:
19,184. (For policy questions regarding
this collection contact Sarah Fulton at
410–786–2749.)
Dated: March 15, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2016–06188 Filed 3–17–16; 8:45 am]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7040–N2]
Health Insurance MarketplaceSM,
Medicare, Medicaid, and the Children’s
Health Insurance Program;
Cancellation of the March 23, 2016
Advisory Panel on Outreach and
Education Meeting
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Cancellation of meeting.
AGENCY:
On February 25, 2016, we
published a Federal Register notice (81
FR 9483) announcing a new meeting of
the Advisory Panel on Outreach and
Education (APOE) (the Panel), which
was scheduled for Wednesday, March
23, 2016. This notice announces the
cancellation of the March 23, 2016
meeting.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Abigail Huffman, Designated Federal
Official, Office of Communications,
CMS, 7500 Security Boulevard, Mail
Stop S1–05–06, Baltimore, MD 21244,
410–786–0897, email
Abigail.Huffman1@cms.hhs.gov.
Additional information about the APOE
is available on the Internet at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html.
Press inquiries are handled through the
CMS Press Office at (202) 690–6145.
Dated: March 15, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2016–06206 Filed 3–17–16; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–3543]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Quantitative
Information in Direct-to-Consumer
Television Advertisements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
SUMMARY:
VerDate Sep<11>2014
19:50 Mar 17, 2016
Jkt 238001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
14855
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by April 18,
2016.
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910-New and
title ‘‘Quantitative Information in
Direct-to-Consumer Television
Advertisements.’’ Also include the FDA
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
ADDRESSES:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Quantitative Information in Direct-toConsumer Television Advertisements
OMB Control Number 0910—NEW
I. Background
Section 1701(a)(4) of the Public
Health Service Act (42 U.S.C.
300u(a)(4)) authorizes FDA to conduct
research relating to health information.
Section 1003(d)(2)(C) of the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) (21 U.S.C. 393(d)(2)(C))
authorizes FDA to conduct research
relating to drugs and other FDA
regulated products in carrying out the
provisions of the FD&C Act.
A previous FDA study found that
simple quantitative information could
be conveyed in direct-to-consumer
(DTC) television ads in ways that
increased consumer’s knowledge about
the drug (OMB control number 0910–
0663, ‘‘Experimental Study:
Presentation of Quantitative
Effectiveness Information to Consumers
in Direct-to-Consumer (DTC) Television
and Print Advertisements for
Prescription Drugs’’) (Ref. 1). However,
this research only tested simple
information (e.g., one clinical trial,
comparison to placebo). Drug
information can be much more
complicated (e.g., complicated
endpoints, multiple study arms). The
E:\FR\FM\18MRN1.SGM
18MRN1
Agencies
[Federal Register Volume 81, Number 53 (Friday, March 18, 2016)]
[Notices]
[Page 14855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06206]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7040-N2]
Health Insurance Marketplace\SM\, Medicare, Medicaid, and the
Children's Health Insurance Program; Cancellation of the March 23, 2016
Advisory Panel on Outreach and Education Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Cancellation of meeting.
-----------------------------------------------------------------------
SUMMARY: On February 25, 2016, we published a Federal Register notice
(81 FR 9483) announcing a new meeting of the Advisory Panel on Outreach
and Education (APOE) (the Panel), which was scheduled for Wednesday,
March 23, 2016. This notice announces the cancellation of the March 23,
2016 meeting.
FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail
Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email
Abigail.Huffman1@cms.hhs.gov. Additional information about the APOE is
available on the Internet at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through
the CMS Press Office at (202) 690-6145.
Dated: March 15, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2016-06206 Filed 3-17-16; 8:45 am]
BILLING CODE 4120-01-P